Back to Search Start Over

Epidural and intrathecal n-butyl-p-aminobenzoate solution in the rat. Comparison with bupivacaine.

Authors :
Grouls RJ
Meert TF
Korsten HH
Hellebrekers LJ
Breimer DD
Source :
Anesthesiology [Anesthesiology] 1997 Jan; Vol. 86 (1), pp. 181-7.
Publication Year :
1997

Abstract

Background: Epidural administration of an aqueous suspension of n-butyl-p-aminobenzoate (BAB) to humans results in long-lasting sensory blockade without motor block. The dose-response of BAB administered epidurally and intrathecally as a solution was studied in rats to define the local anesthetic properties in an established animal model.<br />Methods: The time course of changes in tail withdrawal latency and motor function were determined in rats after epidural or intrathecal administration of solutions of BAB or bupivacaine. The dose-response relation was determined and median effective dose values were calculated.<br />Results: After epidural and intrathecal administration of BAB solutions, the onset and duration of the antinociceptive action were comparable to bupivacaine. Median effective dose values for tail-withdrawal latency of 6 s or more were significantly greater for BAB. After both routes of administration, BAB clearly affected motor function.<br />Conclusions: When administered epidurally and intrathecally as a solution, BAB is a local anesthetic of relative low potency with onset and duration of action comparable to those of bupivacaine. These findings suggest that the long-lasting action obtained after applying BAB suspension results from the slow dissolution (continuous release) of the solid BAB deposited in the epidural space.

Details

Language :
English
ISSN :
0003-3022
Volume :
86
Issue :
1
Database :
MEDLINE
Journal :
Anesthesiology
Publication Type :
Academic Journal
Accession number :
9009953
Full Text :
https://doi.org/10.1097/00000542-199701000-00022